Skip to content

Scientific Technology News

About STN
Contact Us

Top-10
Instrument Industry Deals
Product Launches

FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma

March 23, 2017October 19, 2019 by /

Share This.....

Share on linkedin

Share on twitter

Share on facebook

Share on google

Related News:

Roche receives FDA approval for first companion…
Rakuten Medical and Shimadzu Enroll First Patient in…
European Commission approves Roche’s Tecentriq SC,…
FDA grants priority review to Roche’s bispecific…
Roche’s Polivy combination approved by European…
Shimadzu, Providence Cancer Institute, and Japanese…

Category: Acad, Gov/Utilities, Atomic Spectroscopy

Post navigation

Previous PostPerkinElmer to Display Portfolio of Cancer Research Technologies and Workflow Solutions at 2017 AACR Annual Meeting

Next PostZymo Research and Hamilton Robotics Forge Partnership to Automate Epigenetics Research

Get market data and industry analysis here. Request a complimentary copy.

Related News

Roche receives FDA approval for first companion… October 4, 2022
Rakuten Medical and Shimadzu Enroll First Patient in… February 16, 2022
European Commission approves Roche’s Tecentriq SC,… January 16, 2024
FDA grants priority review to Roche’s bispecific… January 6, 2023
Roche’s Polivy combination approved by European… May 25, 2022
Shimadzu, Providence Cancer Institute, and Japanese… December 19, 2022
[Ad hoc announcement pursuant to Art. 53 LR] Roche… May 11, 2022
GE Healthcare Receives FDA Approval of First-Ever… April 4, 2022
U.S. FDA grants priority review to Roche’s… April 4, 2022
FDA grants Priority Review to Roche’s Lunsumio for… July 6, 2022

© 2025 Scientific Technology News